Harbour BioMed gets FDA approval for Phase II NPC trial

PET-CT_scan_of_nasopharyngeal_cancer
FDG-PET/CT scan of a patient with nasopharyngeal cancer. Transverse slice demonstrating FDG-positive primary site. Credit: Gulec SA et al.